CPAP and measures of cardiovascular risk in males with OSAS.

CPAP and measures of cardiovascular risk in males with OSAS.

Obstructive sleep apnoea syndrome (OSAS) has been associated with hypertension, stroke and myocardial ischaemia in epidemiological and observational studies. Continuous positive airway pressure (CPAP) is the treatment of choice for OSAS, but the impact of this intervention on established risk factor...

Detaylı Bibliyografya
Asıl Yazarlar:	Kohler, M, Pepperell, J, Casadei, B, Craig, S, Crosthwaite, N, Stradling, JR, Davies, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2008

Benzer Materyaller

Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP)
Yazar:: Pepperell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

In minimally symptomatic OSA what is the best test to measure CPAP response?
Yazar:: Turnbull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Residual sleepiness in patients with OSA on CPAP.
Yazar:: Stradling, JR
Baskı/Yayın Bilgisi: (2009)

Patterns of CPAP usage in patients with minimally symptomatic OSA
Yazar:: Turnbull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Cardiovascular Risk in Asymptomatic OSA
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial.
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
Yazar:: Tang, I, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK?
Yazar:: Craig, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP
Yazar:: Turnbull, CD, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
Yazar:: Turnbull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
Yazar:: Antoniades, C, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Relative accuracy of algorithm-based prescription of nasal CPAP in OSA.
Yazar:: Stradling, JR, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
Yazar:: John R Stradling, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

A novel, simplified approach to starting nasal CPAP therapy in OSA.
Yazar:: Stradling, JR, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Baseline blood pressure and hypersomnolence predict bp fall with CPAP treatment of OSA
Yazar:: Robinson, G, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

EFFECT OF CPAP TREATMENT FOR OSA ON VISUAL PROCESSING OF DEGRADED WORDS
Yazar:: Proudlove, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
Yazar:: Lettau, F, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
Yazar:: Schwarz, E, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Can autonomic arousals and neural net EEG analysis predict daytime sleepiness and its response to nCPAP in OSA?
Yazar:: Bennett, L, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
Yazar:: Schwarz, E, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial.
Yazar:: Craig, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

COVID-19 related changes in outpatient CPAP set-up pathways for OSA are linked with decreased 30-day CPAP usage
Yazar:: Turnbull, CD, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Does either obesity or OSA severity influence the response of autotitrating CPAP machines in very obese subjects?
Yazar:: Turnbull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Effects of Overnight Supplemental Oxygen on Morning Blood Pressure in a Randomized Controlled CPAP Withdrawal Trial in Patients with OSA
Yazar:: Petousi, N, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Effect of CPAP on depressive symptoms in OSA
Yazar:: Samy S. Eldahdouh, ve diğerleri
Baskı/Yayın Bilgisi: (2014-04-01)

Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial
Yazar:: Craig, S, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

CPAP increases bronchial reactivity in OSAS patients
Yazar:: P. Korczyski, ve diğerleri
Baskı/Yayın Bilgisi: (2008-06-01)

Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
Yazar:: Craig, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity.
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA).
Yazar:: Robinson, G, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Platelet activation is increased in obstructive sleep apnoea and does not fall with CPAP treatment
Yazar:: Robinson, G, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial
Yazar:: Miaochan Lao, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Metabolic Sydrome Prediction in Mild/Moderate OSA Patients - Anthropometric Measures and Abdominal Fat Estimations by MRI
Yazar:: Craig, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) ON DIURNAL SODIUM AND WATER-EXCRETION IN OBSTRUCTIVE SLEEP-APNEA (OSA)
Yazar:: Warley, A, ve diğerleri
Baskı/Yayın Bilgisi: (1987)

Oximetry derivatives in the assessment of OSA
Yazar:: Bennett, L, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

OSA and hypertension: do we know all the answers?
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Baroreflex sensitivity increases after 4 weeks of nasal continuous positive airway presure therapy in patients with obstructive sleep apnoea
Yazar:: Pepperell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

DIABETIC MACULAR OEDEMA (DME) AND OBSTRUCTIVE SLEEP APNOEA (OSA)-VISUAL IMPROVIEMENT POST CPAP THERAPY. PROOF OF PRINCIPLE STUDY
Yazar:: Mason, R, ve diğerleri
Baskı/Yayın Bilgisi: (2010)